On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
How can DAOs - Decentralized Autonomous Organizations - improve rare disease research? Biorasi's Few & Far Between Podcast welcomes Dr. Jocelynn Pearl, Senior Scientist...
"I think all disciplines go through a process, a journey of being imagined and then becoming a science and then becoming a discipline of...
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....